Our first guest today is, Ian Jefferies, President and CEO of the Association of American Railroads, he will discuss how trains are keeping the supply chain open during this time of crisis and what it means to the State. Missouri has a long history in the Railroad Industry. Even today, Congressman Sam Graves and US Senator Roy Blunt both serve on Congressional Committees that oversee Freight Railroads. During the Pandemic, Railroads are one segment of the economy that’s been chugging along, despite business closures ad people working from home.
As the Association of American Railroads (AAR’s) president and CEO, Jefferies advocates for and works with member railroads to ensure the continued viability of America’s railroad industry. Prior to assuming the role on January 1, 2019, Jefferies was the senior vice president of AAR’s government affairs where he led the development, promotion and implementation of legislative priorities for the AAR. For more information go to https://www.aar.org/
Wayne Eskridge, Founder of the Fatty Liver Foundation and cirrhosis patient, along with Donna Cryer, President and CEO of the Global Liver Institute, will be available to discuss the significance of International NASH Day and the virtual events to mark the day. They will also talk about the mission, duty, and purpose of the Fatty Liver Foundation to educate, coordinate, and support victims of the growing epidemic of fatty liver disease.
International NASH Day on June 12th, 2020 will be dedicated to increasing awareness of NASH (non-alcoholic steatohepatitis). NASH is the progressive form of nonalcoholic fatty liver disease (NAFLD) and affects more than 115 million people worldwide with about 20 million impacted in the US. An estimated 357 million people will be affected by 2030.
International NASH Day will highlight actions people can take to prevent, identify, and treat the disease. NASH often progresses without easily visible symptoms and is commonly not identified before it becomes life threatening. It is critical that the general public, at-risk patients, the medical community, public health authorities, policymakers, and the media learn more about NASH and associated diseases, such as liver cancer, that are becoming more prevalent in our society. For more Information go to: https://www.fattyliverfoundation.org/ and https://www.globalliver.org/